Applications of MOSkin dosimeters for quality assurance in gynecological HDR brachytherapy: An in-phantom feasibility study

Anna A. Romanyukha, Mauro Carrara, Chiara Tenconi, Davide Mazzeo, Giulio Rossi, Marta Borroni, Emanuele Pignoli, Annamaria Cerrotta, Dean Cutajar, Marco Petasecca, Michael Lerch, Joseph Bucci, Anatoly B. Rosenfeld

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

In vivo dosimetry (IVD) is an excellent mode of treatment verification and detection of possible overexposures. A feasibility study was conducted to evaluate a proposed IVD procedure for gynecological HDR brachytherapy procedure quality assurance. MOSkin dosimeters were selected due to their small size and capability of measuring steep dose gradients, such as those relevant in HDR brachytherapy procedures. Two in-phantom experiments measuring dose with MOSkins at the position simulating the rectal wall were conducted employing a cylindrical single channel applicator and a multichannel applicator. Three MOSkins were incorporated onto a rectal catheter, which was then attached to the applicator, separated by a small wooden plaque, simulating the vaginal to rectal wall distance and fixing catheter position. This setup was inserted into a water phantom and three treatment plans prescribing 300 cGy to 3 different targets were assigned with various dose distributions. Each treatment was administered three times, and doses measured by the MOSkins were recorded. Doses measured by the MOSkins were within 5% of the dose determined by the treatment planning system (TPS), ranging between 208 and 332 cGy, depending on dosimeter position on the rectal catheter. The overall average dose difference between measured and TPS values was 2.09% ± 1.15% (ranging between 0.83 and 4.27%, with measured values always higher than TPS dose), subdivided in 1.40 ± 0.37% and 2.79 ± 1.27% for single and multichannel applicator experiments, respectively. An overall dose agreement between the TPS and measured values, detector reproducibility, and practicality of the rectal catheter demonstrated the suitability of the proposed method for in vivo real time QA purposes in gynecological HDR brachytherapy.

Original languageEnglish
Pages (from-to)399-404
Number of pages6
JournalRadiation Measurements
Volume106
DOIs
Publication statusPublished - Nov 1 2017

Fingerprint

Applicators
Dosimeters
Catheters
assurance
Quality assurance
dosimeters
Planning
dosage
Dosimetry
planning
Experiments
Detectors
Water
fixing
gradients
detectors

Keywords

  • Gynecological brachytherapy
  • HDR brachytherapy
  • In vivo dosimetry
  • MOSFET

ASJC Scopus subject areas

  • Radiation
  • Instrumentation

Cite this

Applications of MOSkin dosimeters for quality assurance in gynecological HDR brachytherapy : An in-phantom feasibility study. / Romanyukha, Anna A.; Carrara, Mauro; Tenconi, Chiara; Mazzeo, Davide; Rossi, Giulio; Borroni, Marta; Pignoli, Emanuele; Cerrotta, Annamaria; Cutajar, Dean; Petasecca, Marco; Lerch, Michael; Bucci, Joseph; Rosenfeld, Anatoly B.

In: Radiation Measurements, Vol. 106, 01.11.2017, p. 399-404.

Research output: Contribution to journalArticle

Romanyukha, Anna A. ; Carrara, Mauro ; Tenconi, Chiara ; Mazzeo, Davide ; Rossi, Giulio ; Borroni, Marta ; Pignoli, Emanuele ; Cerrotta, Annamaria ; Cutajar, Dean ; Petasecca, Marco ; Lerch, Michael ; Bucci, Joseph ; Rosenfeld, Anatoly B. / Applications of MOSkin dosimeters for quality assurance in gynecological HDR brachytherapy : An in-phantom feasibility study. In: Radiation Measurements. 2017 ; Vol. 106. pp. 399-404.
@article{39f35b8e31ee475396688d2fe0f2de07,
title = "Applications of MOSkin dosimeters for quality assurance in gynecological HDR brachytherapy: An in-phantom feasibility study",
abstract = "In vivo dosimetry (IVD) is an excellent mode of treatment verification and detection of possible overexposures. A feasibility study was conducted to evaluate a proposed IVD procedure for gynecological HDR brachytherapy procedure quality assurance. MOSkin dosimeters were selected due to their small size and capability of measuring steep dose gradients, such as those relevant in HDR brachytherapy procedures. Two in-phantom experiments measuring dose with MOSkins at the position simulating the rectal wall were conducted employing a cylindrical single channel applicator and a multichannel applicator. Three MOSkins were incorporated onto a rectal catheter, which was then attached to the applicator, separated by a small wooden plaque, simulating the vaginal to rectal wall distance and fixing catheter position. This setup was inserted into a water phantom and three treatment plans prescribing 300 cGy to 3 different targets were assigned with various dose distributions. Each treatment was administered three times, and doses measured by the MOSkins were recorded. Doses measured by the MOSkins were within 5{\%} of the dose determined by the treatment planning system (TPS), ranging between 208 and 332 cGy, depending on dosimeter position on the rectal catheter. The overall average dose difference between measured and TPS values was 2.09{\%} ± 1.15{\%} (ranging between 0.83 and 4.27{\%}, with measured values always higher than TPS dose), subdivided in 1.40 ± 0.37{\%} and 2.79 ± 1.27{\%} for single and multichannel applicator experiments, respectively. An overall dose agreement between the TPS and measured values, detector reproducibility, and practicality of the rectal catheter demonstrated the suitability of the proposed method for in vivo real time QA purposes in gynecological HDR brachytherapy.",
keywords = "Gynecological brachytherapy, HDR brachytherapy, In vivo dosimetry, MOSFET",
author = "Romanyukha, {Anna A.} and Mauro Carrara and Chiara Tenconi and Davide Mazzeo and Giulio Rossi and Marta Borroni and Emanuele Pignoli and Annamaria Cerrotta and Dean Cutajar and Marco Petasecca and Michael Lerch and Joseph Bucci and Rosenfeld, {Anatoly B.}",
year = "2017",
month = "11",
day = "1",
doi = "10.1016/j.radmeas.2016.12.010",
language = "English",
volume = "106",
pages = "399--404",
journal = "Radiation Measurements",
issn = "1350-4487",
publisher = "Elsevier Limited",

}

TY - JOUR

T1 - Applications of MOSkin dosimeters for quality assurance in gynecological HDR brachytherapy

T2 - An in-phantom feasibility study

AU - Romanyukha, Anna A.

AU - Carrara, Mauro

AU - Tenconi, Chiara

AU - Mazzeo, Davide

AU - Rossi, Giulio

AU - Borroni, Marta

AU - Pignoli, Emanuele

AU - Cerrotta, Annamaria

AU - Cutajar, Dean

AU - Petasecca, Marco

AU - Lerch, Michael

AU - Bucci, Joseph

AU - Rosenfeld, Anatoly B.

PY - 2017/11/1

Y1 - 2017/11/1

N2 - In vivo dosimetry (IVD) is an excellent mode of treatment verification and detection of possible overexposures. A feasibility study was conducted to evaluate a proposed IVD procedure for gynecological HDR brachytherapy procedure quality assurance. MOSkin dosimeters were selected due to their small size and capability of measuring steep dose gradients, such as those relevant in HDR brachytherapy procedures. Two in-phantom experiments measuring dose with MOSkins at the position simulating the rectal wall were conducted employing a cylindrical single channel applicator and a multichannel applicator. Three MOSkins were incorporated onto a rectal catheter, which was then attached to the applicator, separated by a small wooden plaque, simulating the vaginal to rectal wall distance and fixing catheter position. This setup was inserted into a water phantom and three treatment plans prescribing 300 cGy to 3 different targets were assigned with various dose distributions. Each treatment was administered three times, and doses measured by the MOSkins were recorded. Doses measured by the MOSkins were within 5% of the dose determined by the treatment planning system (TPS), ranging between 208 and 332 cGy, depending on dosimeter position on the rectal catheter. The overall average dose difference between measured and TPS values was 2.09% ± 1.15% (ranging between 0.83 and 4.27%, with measured values always higher than TPS dose), subdivided in 1.40 ± 0.37% and 2.79 ± 1.27% for single and multichannel applicator experiments, respectively. An overall dose agreement between the TPS and measured values, detector reproducibility, and practicality of the rectal catheter demonstrated the suitability of the proposed method for in vivo real time QA purposes in gynecological HDR brachytherapy.

AB - In vivo dosimetry (IVD) is an excellent mode of treatment verification and detection of possible overexposures. A feasibility study was conducted to evaluate a proposed IVD procedure for gynecological HDR brachytherapy procedure quality assurance. MOSkin dosimeters were selected due to their small size and capability of measuring steep dose gradients, such as those relevant in HDR brachytherapy procedures. Two in-phantom experiments measuring dose with MOSkins at the position simulating the rectal wall were conducted employing a cylindrical single channel applicator and a multichannel applicator. Three MOSkins were incorporated onto a rectal catheter, which was then attached to the applicator, separated by a small wooden plaque, simulating the vaginal to rectal wall distance and fixing catheter position. This setup was inserted into a water phantom and three treatment plans prescribing 300 cGy to 3 different targets were assigned with various dose distributions. Each treatment was administered three times, and doses measured by the MOSkins were recorded. Doses measured by the MOSkins were within 5% of the dose determined by the treatment planning system (TPS), ranging between 208 and 332 cGy, depending on dosimeter position on the rectal catheter. The overall average dose difference between measured and TPS values was 2.09% ± 1.15% (ranging between 0.83 and 4.27%, with measured values always higher than TPS dose), subdivided in 1.40 ± 0.37% and 2.79 ± 1.27% for single and multichannel applicator experiments, respectively. An overall dose agreement between the TPS and measured values, detector reproducibility, and practicality of the rectal catheter demonstrated the suitability of the proposed method for in vivo real time QA purposes in gynecological HDR brachytherapy.

KW - Gynecological brachytherapy

KW - HDR brachytherapy

KW - In vivo dosimetry

KW - MOSFET

UR - http://www.scopus.com/inward/record.url?scp=85009232062&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85009232062&partnerID=8YFLogxK

U2 - 10.1016/j.radmeas.2016.12.010

DO - 10.1016/j.radmeas.2016.12.010

M3 - Article

AN - SCOPUS:85009232062

VL - 106

SP - 399

EP - 404

JO - Radiation Measurements

JF - Radiation Measurements

SN - 1350-4487

ER -